HIV Protease Substrate 1 (TFA)

HIV Protease Substrate 1 (TFA)

• UNSPSC Description: HIV Protease Substrate 1 TFA, a fiuorogenic HIV protease substrate, can be used to study enzymatic activity of HIV protease[1].
• Target Antigen: HIV Protease
• Type: Peptides
• Related Pathways: Anti-infection;Metabolic Enzyme/Protease
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/hiv-protease-substrate-1-tfa.html
• Solubility: 10 mM in DMSO
• Smiles: O=C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCC(NCCNC1=CC=CC2=C1C=CC=C2S(=O)(O)=O)=O)NC([C@H](CCCNC(N)=N)N)=O)=O)CO)=O)CCC(N)=O)=O)CC(N)=O)=O)CC3=CC=C(O)C=C3)N4[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)CCCCNC(C5=CC=C(/N=N/C6=CC=C(N(C)C)C=C6)C=C5)=O)=O)CCC(N)=O)=O)C(C)C)=O)[C@H](CC)C)=O)CCC4.O=C(O)C(F)(F)F
• Molecular Weight: 2131.29
• References & Citations: [1]Kapewangolo P, et al. Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a. Molecules. 2017;22(11):1763. Published 2017 Nov 6.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported